Tegileridine

DB18988InvestigationalSmall molecule

Tegileridine is under investigation in clinical trial NCT06458400 (To Evaluate the Efficacy and Safety of Tegileridine and Oliceridine Injections in the Treatment of Postoperative Pain).

Mechanism: Pharmacologically active on Mu-type opioid receptor
Curator reviewed
Formula / weight: C₂₈H₃₈N₂O₂ · 434.624 g/mol (avg)

Resolves to

Compound

UNIIYFJS8L4TGUCAS2095345-66-5

Structure

InChIKeyYUMLNLMFBWBKSK-OHSXHVKISA-NSMILESCCO[C@H]1CC[C@H](NCC[C@]2(CCOC3(CCCC3)C2)C2=CC=CC=N2)C2=CC=CC=C12

Targets

P35372OPRM1

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

12Clinical trialsPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tegileridine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account